Back to Clinical Trials Overview

Your search for "Kidney" returned 15 results:


Fibromuscular dysplasia international society registry
Principal Investigator(s): Olin, Jeffrey W.

A Multi-center, double-blind, randomized study evaluating de novo weekly and once every 2 week darbepoetin alfa dosing for the correction of anemia in pediatric subjects with chronic kidney disease recieving and not receiving dialysis
Principal Investigator(s): Benchimol, Corinne

RENALGUARD: A Study to Evaluate RenalGuard™ System Safety and Efficacy when Compared with Standard Care in the Prevention of Contrast Induced Nephropathy in the Setting of a Catheterization Laboratory
Principal Investigator(s): Michael Kim, MD

Efficacy and Safety of Sparsentan (RE-021) A Dual Endothelin Receptor and Angiotensin Receptor Blocker In Patients with Focal Segmental Glomerulosclerosis (FSGS): A Randomized Double-Blind Active-Control Dose-Escalation Study
Principal Investigator(s): Kirk Campbell

Phase 2 Prospective, Randomized, Double-Arm, Deferred Treatment, Open-Label, Repeat Dose, Safety and Efficacy Study of Autologous Neo-Kidney Augment (NKA) in Subjects with Type 2 Diabetes and Chronic Kidney Disease
Principal Investigator(s): Steven Coca

A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease
Principal Investigator(s): Jonathan Winston

Genomics of Chronic Renal Allograft Rejection
Principal Investigator(s): Murphy, Barbara M.D.

Evaluation of Sodium Bicarbonate to Reduce Contrast-Induced Nephropathy (CIN) in Subjects with Advanced Chronic Kidney Disease (CKD) who are Undergoing Angiography [BOSS TRIAL]
Principal Investigator(s): Michael Kim

A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Proliferative Lupus Nephritis
Principal Investigator(s): Kirk Campbell

A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease in addition to standard of care
Principal Investigator(s): Jonathan Winston

A Phase 3, prospective, multicenter, double-blind, randomized, active control study to demonstrate the safety and effectiveness of Neutrolin® in preventing catheter-related bloodstream infections in subjects receiving hemodialysis therapy as treatment for end stage renal disease
Principal Investigator(s): Vijay Lapsia

Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic Focal Segmental Glomerulosclerosis: A 2 Part Prospective Study of H.P. Acthar® Gel (PODOCYTE)
Principal Investigator(s): Kirk Campbell

WTC RENAL (Renal and Cardiovascular Impairment in WTC Responders: Implications for Diagnosis and Treatment)
Principal Investigator(s): Mary Ann McLaughlin

Effects of Sevelamer Carbonate on Oxidative Stress in patients with Diabetic Nephopathy
Principal Investigator(s): Vlassara, Helen

Chronic Kidney Disease in Children Study (C-Kid)
Principal Investigator(s): Saland, Jeffrey M